Merck (MRK) Treasury Shares (2009 - 2026)

Merck (MRK) has reported Treasury Shares for 18 consecutive years, with $64.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares rose 6.01% year-over-year to $64.1 billion in Q2 2026; TTM through Jun 2026 was $64.1 billion, a 6.01% increase from a year earlier, with the FY2025 full-year figure at $63.0 billion, up 8.05% from the prior year.
• Treasury Shares was $64.1 billion for Q2 2026 at Merck, up from $63.7 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $1.1 billion in Q2 2026 and troughed at $1.0 billion in Q2 2023.
• A 5-year average of $1.1 billion and a median of $1.0 billion in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares decreased 1.09% in 2022 and climbed 8.05% in 2025, its largest moves.
• Over 5 years, Treasury Shares stood at $56.5 billion in 2022, then rose by 1.7% to $57.4 billion in 2023, then rose by 1.48% to $58.3 billion in 2024, then climbed by 8.05% to $63.0 billion in 2025, then climbed by 1.8% to $64.1 billion in 2026.
• The last three Treasury Shares figures came in at $64.1 billion (Q2 2026), $63.7 billion (Q1 2026), and $63.0 billion (Q4 2025), per Business Quant data.